Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.44% inched 0.35% higher to $159.75 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.84% rising 1.32% to 4,655.27 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.51% rising 0.68% to 35,135.94. The stock's rise snapped a two-day losing streak. Johnson & Johnson closed $20.17 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -0.52% rose 1.69% to $390.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.20% fell 5.39% to $74.89, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.53% fell 2.96% to $52.40. Trading volume (9.2 M) eclipsed its 50-day average volume of 6.6 M.